Combining Etoposide and Photosensitization in Leukemia Cells
Author Information
Author(s): TG Gantchev, N Brasseur, JE van Lier
Primary Institution: Department of Nuclear Medicine and Radiobiology, Faculty of Medicine, University of Sherbrooke
Hypothesis
Photodynamic therapy (PDT) in conjunction with etoposide could result in enhanced cytotoxicity.
Conclusion
The combination of etoposide and photosensitization showed synergistic toxicity in K562 human leukaemic cells.
Supporting Evidence
- The combination treatment resulted in supra-additive accumulation of cells in the G2/M phase of the cell cycle.
- Internucleosomal DNA fragmentation was significantly increased with combined treatment.
- AlPcS4 photosensitisation was shown to induce oxidative damage to DNA.
Takeaway
Using light to activate a special dye along with a cancer drug can make the drug work better against leukemia cells.
Methodology
K562 human leukaemic cells were treated with etoposide and aluminium tetrasulphonated phthalocyanine, followed by light exposure, and various assays were performed to assess cell viability and DNA fragmentation.
Limitations
The study was conducted in vitro, and the results may not directly translate to clinical settings.
Participant Demographics
K562 human leukaemic cells were used in the study.
Want to read the original?
Access the complete publication on the publisher's website